Here are relevant reports on : drug-safety-market
-
Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030
The global cell-based assays market, valued at US$17.36B in 2024, is forecasted to grow at a 9.1% CAGR, reaching US$18.134B by 2025 and US$25.77B by 2030. Growth in this market is primarily driven by the increasing demand for drug discovery and development, the increasing preference for cell-based assays in drug discovery, and the rising prevalence of cancer.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors (Auto Injectors), Implantable, Transmucosal, Nasal, Syringes), Application (Cancer, Diabetes), Care Setting (Hospital, Home Care) - Forecast to 2031
The Asia Pacific pharmaceutical drug delivery market, valued at US$457.9 million in 2025, stood at US$479.7 million in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of US$687.9 million by the end of the period. The market growth for drug delivery in the APAC region is steadily expanding due to an increase in disease prevalence, an increase in the adoption rate of biologics, advancements in technologies, and an increase in regional production.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Motor Lamination Market by Application (Performance, Comfort, and Safety), Material, Technology, Motor Type (Power Steering & Window, Adaptive front light), ICE & Electric Vehicle, ATV by Application and Region - Global Forecast to 2027
The motor lamination market is projected to reach USD 27.6 billion by 2027 at a CAGR of 4.7% during the forecast period. The motor lamination market is dominated by a few global players and comprises several regional players. Some of the key manufacturers and suppliers of the motor lamination market are Tempel (US), Pitti Engineering Ltd (India), Alinabal, Inc (US), EuroGroup Laminations S.p.A. (Italy), R. Bourgeois (France), and LCS Company (US).
- Published: December 2022
- Price: $ 4950
- TOC Available:
-
Push-to-talk Market by Offering (Hardware, Solutions, and Services), Network Type (LMR and Cellular), Vertical (Government & Public Safety, Aerospace & Defense, and Transportation & Logistics) and Region - Global Forecast to 2028
The push-to-talk (PTT) market is projected to reach USD 57.4 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period. The major vendors covered in the PTT market AT&T Inc. (US); Verizon Wireless (US); Motorola Solutions, Inc. (US); T-Mobile (US); Qualcomm Incorporated (US); Zebra Technologies Corporation (US); Telstra Group Limited (Australia); Hytera Communications Corporation Limited (China); Telefonaktiebolaget LM Ericsson (Sweden); Bell Canada (Canada); Iridium Communications Inc. (US); Tait Communications (New Zealand); Airbus SE (Netherlands); L3Harris Technologies, Inc. (US); ServiceMax, a PTC Technology (US); Simoco Wireless Solutions (UK); GroupTalk (Sweden); Orion Labs, Inc. (US); Zello Inc. (US); Procore Technologies, Inc. (US); VoxerNet LLC (US); International Push to Talk Ltd (England); Enterprise Secure Chat (US); AINA Wireless (US); Azetti Networks (Spain); PeakPTT (US); RugGear (China); ProMobi Technologies (India); and TeamConnect (US).
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
High Altitude Equipment Market by Product Type (Survival, Safety, Medical Emergencies), Application (Recreational Activates, Military) & Geography - Global Forecasts to 2020
At high altitudes survival and safety becomes very important and getting through such environment requires certain type of gears and equipment. Survival without such equipment becomes very difficult. Medical emergencies need to be handled efficiently and with care. Equipment specifically designed for high altitude make it easier to handle such situations.. The atmosphere is very harsh and extreme at high altitudes, mostly adventure enthusiast or military personnel have to live in such conditions. The lack of oxygen at high altitudes can cause serious illnesses such as altitude sickness, high altitude pulmonary edema, and high altitude cerebral edema.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Optical Brighteners Market by Application (Paper, Fabrics, Detergents & Soaps, Synthetics & Plastics & Others), by End User (Consumer Products, Textiles & Apparel, Packaging, Security & Safety & Others) - Global Forecast to 2020
The global optical brighteners market size is estimated to reach USD 1.05 Billion by 2020 at a CAGR of 9.6% between 2015 and 2020. The report segments the market by application into paper, fabrics, detergents & soaps, synthetics & plastics, and others, by end-users into consumer products, security & safety, textiles & apparel, packaging, and by region into Asia-Pacific, North America, Europe, and RoW. Base year considered for the study is 2014, while the forecast period is between 2015 and 2020.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Predictive Vehicle Technology Market by Application (Proactive alerts, Safety & Security), Hardware (ADAS component, OBD and Telematics), Deployment (On premise and Cloud), End User, Vehicle, and Region - Global Forecast to 2027
The predictive vehicle technology market is expected to grow from USD 20.8 billion in 2019 to USD 90.2 billion by 2027, at a compound annual growth rate (CAGR) of 20.1% during the forecast period.The major market players include Bosch (Germany), Continental (Germany), Valeo (France), Garrett Motion (Switzerland), Aisin Seiki (Japan), and Aptiv (UK), among others.
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Glycomics Market / Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
The global glycomics market in terms of revenue was estimated to be worth $1.8 Billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 15.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Vascular Access Device Market by Type [Central, Peripheral Venous (PIVC, Midline, Arterial), Intraosseous], Route of Insertion, Application [Drug, Fluid Administration, Diagnostic & Testing], End User [Hospital (Public, Private)] - Forecast to 2031
The vascular access device market, valued at USD 5.92 billion in 2025, stood at USD 6.27 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 8.68 billion by the end of the period. The market's expansion is attributed to the increasing prevalence of chronic diseases requiring frequent or long-term treatment through IV, such as cancer, heart disease, and kidney failure.
- Published: May 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
